Arquivamento definitivo - Art. 33 da LPI
#11.1.1
03/07/2023
RPI 2722
Application data
Number
112021004527Type
Filing
Publication
PCT
US2019050843 The application was abandoned: examination was not requested within the 36 months following the 09/12/2019 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 03/07/2023. We update with every new RPI gazette, published weekly.
Applicants
SPECTRUM PHARMACEUTICALS, INC.
CA
Inventors
G. R. (pessoa física)
US
IPC Classification
Priority claims
US
62/731,500 · 09/14/2018
Abstract
KITS E MÉTODOS PARA TRATAMENTO CONTRA CÂNCER.Trata-se de um kit que contém uma forma cristalina de um composto de quinazolina. Mais particularmente, a forma cristalina é derivada do composto de 1-(4-(4-(3,4-dicloro-2-fluorofenilamino)-7-metoxiquinazolin-6-iloxi)piperidin-1-il)prop-2-en-1-ona. Além disso, é divulgado um método de tratamento contra cânceres com a forma cristalina ou um kit da mesma.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
03/07/2023
RPI 2722
#11.1
12/20/2022
RPI 2711
#1.3
06/08/2021
RPI 2631
#1.1
03/23/2021
RPI 2620
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.